Recent Posts in Hot Topics Category
112 results found. Viewing page 1 of 5.
Go to page
CNN recently took a critical investigative look at Johnson & Johnson—their iconic brand and products, and their never-ending legal woes stemming from their asbestos contaminated talcum powder. The hour-long episode delves into the ...
Continue Reading...
In the ongoing legal battle involving Johnson & Johnson’s use of the much-criticized Texas Two-Step, J&J now plans to appeal to the U.S. Supreme Court. We previously reported J&J’s loss in the 3 rd Circuit Court of Appeals ...
Continue Reading...
Following-up on his remarks from last year, in which he condemned Johnson & Johnson’s “cynical” and controversial bankruptcy plan, Senator Dick Durbin once again criticized Johnson & Johnson’s attempt to escape ...
Continue Reading...
In 2017 industrial giant Georgia Pacific was the first company to create a subsidiary unit to offload its asbestos litigation liability which then declared bankruptcy. The tactic is now referred to as the Texas Two-Step and is being used by more and ...
Continue Reading...
In a win for mesothelioma plaintiffs, a three-judge panel in the Federal Appeals Court/Third Circuit court of Philadelphia has unanimously ruled that Johnson & Johnson cannot use bankruptcy to sidestep more than 40,000 talcum-powder lawsuits. A ...
Continue Reading...
A Phase 1 safety study of single-agent immunotherapy drug, Avelumab, combined with stereotactic body radiation therapy (SBRT) was well-tolerated by mesothelioma patients with no severe side effects. The study was led by researchers from Memorial ...
Continue Reading...
Experienced gardeners and green thumb amateurs alike have all encountered potting soil mixes. What they may not realize is that one of the top three ingredients in potting soil, vermiculite, not only takes a carbon-intensive toll on the environment ...
Continue Reading...
ProPublica has released a must-read investigative report on the remaining hold-out in the total ban of asbestos in America, the chlor-alkali industry. Specifically, two chemical companies, OxyChem and Olin Corp., whose insistence upon using ...
Continue Reading...
Join us to support the Pacific Mesothelioma Center and enjoy a luxurious evening at the historic Taglyan Complex with games, dinner and drinks, entertainment, and a live and silent auction with magnificent prizes. In addition to raising greater ...
Continue Reading...
Hikers gathered on a beautiful, clear Sunday last month to commemorate the Pacific Mesothelioma Center’s 11th Annual Walk/Hike for Mesothelioma. In-person participants were greeted by ample sunshine and expansive city and mountain views atop ...
Continue Reading...
The French National Health Security Agency (ANSES) issued a press release September 19, 2022, announcing a link between asbestos exposure and laryngeal and ovarian cancers. According to ANSES, between 150 to 170 diagnosis of these cancers each year ...
Continue Reading...
Researchers from Rice University and Baylor College of Medicine have managed to eradicate advanced-stage mesothelioma tumors within days on rodent subjects, laying the groundwork for future human trials. By combining cytokine “drug ...
Continue Reading...
Despite previously discontinuing sales of talc-based baby powder in the U.S. and Canada in 2020 after growing public pressure, Johnson & Johnson still managed to eke out an excuse to continue selling tainted baby powder in global markets. Now, ...
Continue Reading...
U.S. Representative Elaine Luria of Virginia has introduced legislation to prohibit state courts from removing cases to the federal court system. Throughout the United States, when asbestos victims seek restitution from the companies that knowingly ...
Continue Reading...
The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is less than a month away! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills (family and animal ...
Continue Reading...
The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...
Continue Reading...
In June, Revlon Inc., the 90-year-old makeup company filed for bankruptcy protection amid mounting debts. Some of these debts, although not specifically mentioned may be the result of them being named in lawsuits alleging exposure to talc in ...
Continue Reading...
This past April, the Environmental Protection Agency proposed banning the use, manufacture and import of the most pervasive type of asbestos, chrysotile. Although advocates continued to demand a complete ban of all forms of asbestos, the EPA’s ...
Continue Reading...
When it comes to asbestos cancer risks, should workers be treated differently than the general population? That is the question posed in a recent blog opinion published by the Environmental Defense Fund. Unfortunately, the EPA ’s recently ...
Continue Reading...
As Europe aims to reach climate neutrality by 2050, it is grappling with the risk of exposing construction workers to asbestos. Although admirable, Europe’s goal to renovate 220 million buildings in order to “slash energy emissions, ...
Continue Reading...
Nanotechnology has revolutionized multiple industries in its broad application across medical, industrial, consumer and technological sectors. However, certain types of nanotechnology, such as carbon nanotubes (CNTs), have been shown to closely ...
Continue Reading...
SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...
Continue Reading...
Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...
Continue Reading...
Despite the overall decreased use of asbestos nationwide, mesothelioma deaths among women still managed to increase by 25% over the past two decades. This according to death record statistics published by the Centers for Disease Control and ...
Continue Reading...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...
Continue Reading...
112 results found. Viewing page 1 of 5.
Go to page